Aelius Biotech announced that it has raised £1.25 million in a round of funding on November 23, 2023. The transaction included participation from new investors North East Venture Fund, a fund co-managed by Mercia Fund Management Ltd. and Mercia Asset Management PLC.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
34.3 GBX | +0.88% | +0.88% | +13.58% |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+13.58% | 185M | |
+20.09% | 88.09B | |
+16.36% | 26.72B | |
-1.23% | 18.3B | |
+12.42% | 15.11B | |
+2.48% | 15.08B | |
-21.55% | 12.26B | |
+15.94% | 9.63B | |
+23.02% | 9.08B | |
+27.09% | 7.21B |
- Stock Market
- Equities
- MERC Stock
- News Mercia Asset Management PLC
- Aelius Biotech announced that it has received £1.25 million in funding from Mercia Fund Management Ltd., Mercia Asset Management PLC